Coronary Artery Disease Severity in Newly Diagnosed Dysglycemia
Completed
- Conditions
- DysglycemiaCoronary Artery Disease
- Registration Number
- NCT05210972
- Lead Sponsor
- Saud Al Babtain Cardiac Center
- Brief Summary
This cohort study will measure how severe is the coronary artery disease (CAD), at time of CAD diagnosis, clinically and angiographically in the different cohorts of newly diagnosed diabetes and prediabetes versus normal glycemia patients in the study center.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
- All adult patients with consents.
- First time diagnosis of CAD and no prior diagnosis of diabetes milletus (DM), or prediabetes.
- Coronary artery disease confirmed by invasive coronary angiography.
Exclusion Criteria
- Patients with known significant anemia, increased hemoglobin turnover, active hemoglobin drops or on erythropoietin therapy.
- Pregnant and post-partum patients (up to 3 months post-delivery).
- Patients with severe chronic renal failure (estimated glomerular filtration rate (eGFR) < 30 mL/min/1.72 m2).
- Patients on any medications with glucose lowering effects.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Coronary artery disease severity 1 day (During the hospital admission) To measure how severe is the CAD, at time of CAD diagnosis, clinically and angiographically in the different cohorts of newly diagnosed diabetes and prediabetes versus normal glycemia patients.
- Secondary Outcome Measures
Name Time Method Correlation of HbA1c to CAD severity 1 day (During the hospital admission) To correlate the level of HbA1c to the clinical and angiographic severity of CAD in the study populations
Trial Locations
- Locations (1)
Saud Albatain cardiac Center
🇸🇦Dammam, Saudi Arabia
Saud Albatain cardiac Center🇸🇦Dammam, Saudi Arabia